About this trial
This project aims to develop a novel method for identifying early tissue damage related to pressure ulcer (PU) development in vulnerable patients by measuring biomarkers of inflammation on the skin surface. PUs are common and costly injuries that result from prolonged pressure on the skin. Current methods to assess PU risk are unreliable, and the mechanisms of PU development are not well understood. This project contributes to new knowledge of PU etiology as well as the individual variability at a molecular level combined with new knowledge about nursing actions and clinical factors linked to PU progression and outcomes of prevention. The project will use non-invasive techniques and model-based analysis to identify specific biomolecules that reflect individual susceptibility to pressure exposure in different PU risk scenarios.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
acute respiratory failure
previous ICU care
pressure ulcer on measurement site
Trial population
Patients that use oronasal face masks in their ordinary care during routine management regimes of non invasive ventilation.
Trial design
Cohort
Prospective
Treatments tested in this trial
non-invasive ventilation teraphy, NIV
Procedure/SurgeryRoutine management regimes of NIV
Treatment groups
Trial outcomes
Primary outcomes
CTACK
inflammatory biomarker
ENA-78
inflammatory biomarker
Eotaxin
inflammatory biomarker
Eotaxin-2
inflammatory biomarker
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Linkoeping University
Lead sponsor
Region Östergötland
Collaborator
This trial is not recruiting at the moment. You can still explore other options: